Evaluation of Quality of Life and Care Needs of Turkish Patients Undergoing Hematopoietic Stem Cell Transplantation
Table 4
Comparison of FACT-BMT Scale means with patients’ gender, family type, perceived health status, treatment, and history of rehospitalization following transplantation .
(a)
Gender
Mean ± SD
PWB
Female
46
11.26 ± 7.19
−1.229
0.22
Male
54
12.87 ± 6.57
SWB
Female
46
21.01 ± 4.86
−0.953
0.34
Male
54
20.64 ± 3.71
EWB
Female
46
10.39 ± 6.33
−3.262
0.001
Male
54
14.67 ± 5.84
FWB
Female
46
13.78 ± 4.63
−0.392
0.70
Male
54
14.09 ± 4.64
FACT-G
Female
46
56.45 ± 17.58
−1.768
0.08
Male
54
62.27 ± 15.09
BMTS
Female
46
20.70 ± 6.15
−1.431
0.15
Male
54
22.72 ± 6.89
TOI
Female
46
45.74 ± 15.24
−1.215
0.225
Male
54
49.69 ± 15.61
FACT-BMT total score
Female
46
77.14 ± 22.66
−1.757
0.08
Male
54
84.99 ± 20.79
(b)
Type of patient family
Mean ± SD
PWB
Elementary family
73
12.56 ± 7.02
1.245
0.54
Traditional, large family
18
10.89 ± 6.95
Broken family
9
11.11 ± 5.67
SWB
Elementary family
73
20.33 ± 4.02
12.024
0.002
Traditional, large family
18
23.66 ±
Broken family
9
19.00 ± 5.59
EWB
Elementary family
73
12.22 ± 6.43
1.583
0.45
Traditional, large family
18
14.28 ± 5.03
Broken family
9
13.44 ± 8.63
FWB
Elementary family
73
13.73 ± 4.86
3.141
0.21
Traditional, large family
18
15.39 ± 3.76
Broken family
9
12.89 ± 3.79
FACT-G
Elementary family
73
58.84 ± 16.34
1.478
0.48
Traditional, large family
18
64.21 ± 13.30
Broken family
9
56.44 ± 22.59
BMTS
Elementary family
73
21.51 ± 6.93
2.455
0.29
Traditional, large family
18
23.61 ± 6.16
Broken family
9
20.44 ± 4.16
TOI
Elementary family
73
47.79 ± 16.09
0.818
0.66
Traditional, large family
18
49.89 ± 14.84
Broken family
9
44.44 ± 12.15
FACT-BMT total score
Elementary family
73
80.35 ± 22.14
1.392
0.50
Traditional, large family
18
87.82 ± 18.56
Broken family
9
76.89 ± 25.96
(c)
Perceived health status
Mean ± SD
PWB
“Bad”
42
9.48 ± 6.21
11.39
0.003
“Moderate”
46
13.85 ± 6.88
“Good”
12
14.83 ± 6.38
SWB
“Bad”
42
20.54 ± 4.26
0.926
0.63
“Moderate”
46
20.95 ± 4.09
“Good”
12
21.24 ± 5.14
EWB
“Bad”
42
11.40 ± 5.91
3.357
0.19
“Moderate”
46
13.78 ± 6.98
“Good”
12
13.08 ± 5.30
FWB
“Bad”
42
12.31 ± 3.84
10.992
0.004
“Moderate”
46
14.65 ± 4.63
“Good”
12
17.00 ± 5.10
FACT-G
“Bad”
42
53.73 ± 13.81
11.053
0.004
“Moderate”
46
63.24 ± 16.68(1)
“Good”
12
66.15 ± 18.81(1)
BMTS
“Bad”
42
20.98 ± 6.22
2.788
0.25
“Moderate”
46
21.85 ± 6.83
“Good”
12
24.42 ± 6.91
TOI
“Bad”
42
42.76 ± 13.23
10.230
0.006
“Moderate”
46
50.35 ± 15.85
“Good”
12
56.25 ± 16.63
FACT-BMT total score
“Bad”
42
74.70 ± 18.67
9.005
0.011
“Moderate”
46
85.08 ± 22.67
“Good”
12
90.57 ± 24.49
(d)
Current treatment
Mean ± SD
PWB
Acute-phase treatment following transplantation
59
10.22 ± 6.61
11.634
0.003
Outpatient follow-up
29
15.21 ± 5.93
Treatment of complications
12
14.08 ± 7.53
SWB
Acute-phase treatment following transplantation
59
21.08 ± 4.28
1.63
0.44
Outpatient follow-up
29
20.86 ± 4.27
Treatment of complications
12
19.35 ± 4.17
EWB
Acute-phase treatment following transplantation
59
11.59 ± 6.63
5.095
0.08
Outpatient follow-up
29
14.97 ± 5.74
Treatment of complications
12
12.67 ± 5.82
FWB
Acute-phase treatment following transplantation
59
13.25 ± 4.81
4.218
0.12
Outpatient follow-up
29
15.48 ± 4.01
Treatment of complications
12
13.67 ± 4.42
FACT-G
Acute-phase treatment following transplantation
59
56.15 ± 16.43
7.073
0.029
Outpatient follow-up
29
66.52 ± 14.57
Treatment of complications
12
59.76 ± 16.89
BMTS
Acute-phase treatment following transplantation
59
20.36 ± 6.61
5.71
0.06
Outpatient follow-up
29
24.34 ± 6.06
Treatment of complications
12
22.67 ± 6.32
TOI
Acute-phase treatment following transplantation
59
43.83 ± 15.40
10.640
0.005
Outpatient follow-up
29
55.03 ± 12.98(1)
Treatment of complications
12
50.42 ± 15.79
FACT-BMT total score
Acute-phase treatment following transplantation
59
76.51 ± 21.92
8.286
0.016
Outpatient follow-up
29
90.86 ± 18.96(1)
Treatment of complications
12
82.43 ± 22.50
(e)
History of hospitalization after transplantation
Mean ± SD
PWB
No
62
12.68 ± 7.01
−0.956
0.34
Yes
38
11.24 ± 6.65
SWB
No
62
21.55 ± 4.06
−2.110
0.035
Yes
38
19.61 ± 4.35
EWB
No
62
13.45 ± 6.13
−1.362
0.17
Yes
38
11.47 ± 6.74
FWB
No
62
14.68 ± 4.62
−2.013
0.044
Yes
38
12.76 ± 4.40
FACT-G
No
62
62.35 ± 15.01
−2.003
0.045
Yes
38
55.08 ± 17.88
BMTS
No
62
22.74 ± 6.61
−1.921
0.06
Yes
38
20.24 ± 6.39
TOI
No
62
50.10 ± 15.45
−1.851
0.06
Yes
38
44.24 ± 15.05
FACT-BMT total score
No
62
85.10 ± 20.33
−2.014
0.044
Yes
38
75.32 ± 23.29
: Kruskal Wallis test; : Mann–Whitney test; and . PWB: Physical well-being; SWB: social/family well-being; EWB: emotional well-being; FWB: functional well-being; BMTS: Bone Marrow Transplant Subscale; TOI: FACT-BMT Trial Outcome Index; FACT-G total score. Each number refers to the order of the group of each variable. 1: first group: “elementary family group,” “bad perceived health status group,” and “acute-phase treatment following transplantation group”; 2: second group: “traditional, large family group,” “moderate perceived health status group,” and “outpatient follow-up group”; 3: third group: “broken family group,” “good perceived health status group,” and “treatment of complications group.”
